Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Letterio Morgante

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|March 13, 2002
Fahr's diseaseLetterio Morgante, Francesco Trimarchi, Salvatore Benvenga
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2008
The PRIAMO study: background, methods and recruitmentAngelo Antonini, Carlo Colosimo, Roberto Marconi, et al.
Journal of the American Geriatrics Society|February 7, 2008
Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agentGianluca Trifirò, Letterio Morgante, Michele Tari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2007
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control studyPaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2006
Age at menopause predicts age at onset of Parkinson's diseasePaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Tumor diagnosis preceding Parkinson's disease: a case-control studyMarco D'Amelio, Paolo Ragonese, Letterio Morgante, et al.
Therapeutic Drug Monitoring|July 17, 2004
Plasma risperidone concentrations during combined treatment with sertralineEdoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, et al.
Parkinsonism & Related Disorders|August 23, 2016
Speech and gait in Parkinson's disease: When rhythm mattersLucia Ricciardi, Michela Ebreo, Adriana Graziosi, et al.
Pharmacological Research|October 18, 2005
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophreniaConcetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, et al.
Journal of Neurology|April 12, 2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized studyPaolo Barone, Leonardo Scarzella, Roberto Marconi, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|March 13, 2002
Fahr's diseaseLetterio Morgante, Francesco Trimarchi, Salvatore Benvenga
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2008
The PRIAMO study: background, methods and recruitmentAngelo Antonini, Carlo Colosimo, Roberto Marconi, et al.
Journal of the American Geriatrics Society|February 7, 2008
Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agentGianluca Trifirò, Letterio Morgante, Michele Tari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2007
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control studyPaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2006
Age at menopause predicts age at onset of Parkinson's diseasePaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Tumor diagnosis preceding Parkinson's disease: a case-control studyMarco D'Amelio, Paolo Ragonese, Letterio Morgante, et al.
Therapeutic Drug Monitoring|July 17, 2004
Plasma risperidone concentrations during combined treatment with sertralineEdoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, et al.
Parkinsonism & Related Disorders|August 23, 2016
Speech and gait in Parkinson's disease: When rhythm mattersLucia Ricciardi, Michela Ebreo, Adriana Graziosi, et al.
Pharmacological Research|October 18, 2005
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophreniaConcetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, et al.
Journal of Neurology|April 12, 2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized studyPaolo Barone, Leonardo Scarzella, Roberto Marconi, et al.
Pageof 5